ASH2L and central nervous system cancer: Indeed, ASH2L expression was higher in glioblastoma in comparison to low grade gliomas (LGG-Grade 3 and Grade 3); ASH2L was expressed in all glioblastoma subtypes, but enriched for proneural subtype, based on TCGA (Fig. 5F-G).